BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours

INTRODUCTION: Immunotherapy (IO) has transformed the treatment paradigm for a wide variety of solid tumours. However, assessment of response can be challenging with conventional radiological imaging (eg, iRECIST), which do not precisely capture the unique response patterns of tumours treated with IO...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasi, Pashtoon Murtaza, Chakrabarti, Sakti, Sawyer, Sarah, Krainock, Michael, Poklepovic, Andrew, Ansstas, George, Maninder, Minu, Malhotra, Meenakshi, Ensor, Joe, Gao, Ling, Eroglu, Zeynep, Ellers, Sascha, Billings, Paul, Rodriguez, Angel, Aleshin, Alexey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152946/
https://www.ncbi.nlm.nih.gov/pubmed/35636789
http://dx.doi.org/10.1136/bmjopen-2021-060342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152946/
https://www.ncbi.nlm.nih.gov/pubmed/35636789
http://dx.doi.org/10.1136/bmjopen-2021-060342

Ejemplares similares